Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Effect of capsule 'UB03' containing potential probiotic strains for the treatment of patients with irritable bowel syndrome
in Beneficial Microbessudha.ratna@gmail.com
Search for other papers by M. Ratna Sudha in
Current site
Google Scholar
Search for other papers by P. Sawant in
Current site
Google Scholar
Abstract
The objective of this research was to study the efficacy and safety of capsule 'UB03' to treat patients with Irritable Bowel Syndrome (IBS). Thirty patients with Rome II IBS were assigned to receive capsule 'UB03' (10 billion lyophilised bacteria and yeast/capsule produced by Unique Biotech Limited, India) twice daily for 90 days. Assessment of IBS was carried out according with Rome II criteria and their severity for 90 days of treatment with an interval of 30 days. Complete haemogram, serum glutamic pyruvic transaminase, serum creatinine were performed as a part of safety evaluation at the time of inclusion and after 90 days of treatment. There was significant improvement in frequency of defecation (23%), consistency of stool, abdominal discomfort, bloating and flatulence. However, there was no significant change in abdominal pain and mucus in stool. This trial demonstrates that the consumption of capsule 'UB03' containing potential probiotic strains is found to be effective and safe for the treatment of patients with IBS.
Kauf
Sofortzugang erwerben (PDF-Download und unbegrenzter Online-Zugang):
Institutszugang
Melden Sie sich mit Open Athens, Shibboleth oder Ihren institutionellen Anmeldedaten an.
Persönliche Anmeldung
Melden Sie sich mit Ihrem brill.com-Konto an
-
Agreus, L., Svardsud, K., Nyren, O. and Tibblin, G., 1995. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 109: 671-680.
'Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time ' () 109 Gastroenterology : 671 -680.
-
Barone, C., Pettinato, R., Avola, E., Alberti, A., Greco, D., Failla, P. and Romano, C., 2000. Comparison of three probiotics in the treatment of acute diarrhea in mentally retarded children. Minerva Pediatrics 52: 161-165.
'Comparison of three probiotics in the treatment of acute diarrhea in mentally retarded children ' () 52 Minerva Pediatrics : 161 -165.
-
Barrett, J.S., Canale, K.E., Gearry, R.B., Irving, P.M. and Gibson, P.R., 2008. Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World Journal of Gastroenterology 14: 5020-5024.
'Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome ' () 14 World Journal of Gastroenterology : 5020 -5024.
-
Drossman, D.A., Camilleri, M., Mayer, E.A. and Whitehead, W.E., 2002. AGA technical review on irritable bowel syndrome. Gastroenterology 123: 2108-2131.
'AGA technical review on irritable bowel syndrome ' () 123 Gastroenterology : 2108 -2131.
-
Drossman, D.A., Corazziari, E., Delvaux, M., Spiller, R.C., Talley, N.J., Thompson, W.G. and Whitehead, W.E., 2006. Rome III: the functional. gastrointestinal disorders. 3rd ed., Degon Associates, McLean, VA, USA.
-
Drouault-Holowacz, S., Bieuvelet, S., Burckel, A., Cazaubiel, M., Dray, X. and Marteau, P.A., 2008. Double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterology and Clinical Biology 32: 147-152.
'Double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome ' () 32 Gastroenterology and Clinical Biology : 147 -152.
-
Endres, J.R., Clewell, A., Jade, K.A., Farber, T., Hauswirth, J. and Schauss, A.G., 2009. Safety assessment of a proprietary preparation of a novel probiotic, Bacillus coagulans, as a food ingredient. Food and Chemical Toxicology 47: 1231-1238.
'Safety assessment of a proprietary preparation of a novel probiotic, Bacillus coagulans, as a food ingredient ' () 47 Food and Chemical Toxicology : 1231 -1238.
-
Food and Agricultural Organization of the United Nations/World Health Organization (FAO/WHO), 2001. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a joint FAO/WHO Expert Consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Available at: ftp://ftp.fao.org/es/esn/food/probio_report_en.pdf.
-
Faresjo, A., Grodzinsky, E., Johansson, S., Wallander, M.A., Timpka, T. and Akerlind, I., 2007. Psychosocial factors at work and in every day life are associated with irritable bowel syndrome. European Journal of Epidemiology 22: 473-480.
'Psychosocial factors at work and in every day life are associated with irritable bowel syndrome ' () 22 European Journal of Epidemiology : 473 -480.
-
Fox, C.H. and Dang, G., 2004. Probiotics in the prevention and treatment of diarrhea. Journal of Alternative and Complementary Medicine 10: 601-603.
'Probiotics in the prevention and treatment of diarrhea ' () 10 Journal of Alternative and Complementary Medicine : 601 -603.
-
Frank, L., Kleinman, L., Rentz, A., Ciesla, G., Kim, J.J. and Zacker, C., 2002. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clinical Therapy 24: 675-689.
'Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases ' () 24 Clinical Therapy : 675 -689.
-
Gomez-Gil, B., Roque, A., Turnbull, J.F. and Inglis, V., 1998. A review on the use of microorganisms as probiotics. Revista Latinoamericana de Microbiología 40: 166-172.
'A review on the use of microorganisms as probiotics ' () 40 Revista Latinoamericana de Microbiología : 166 -172.
-
Gorbach, S.L., 2000. Probiotics and gastrointestinal health. American Journal of Gastroenterology 95 Suppl.: S2-S4.
-
Guandalini, S., Pensabene, L., Zikri, M.A., Dias, J.A., Casali, L.G., Hoekstra, H., Kolacek, S., Massar, K., Micetic-Turk, D., Papadopoulou, A., De Sousa, J.S., Sandhu, B., Szajewska, H. and Weizman, Z., 2000. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. Journal of Pediatric Gastroenterology and Nutrition 30: 54-60.
-
Guyonnet, D., Chassany, O., Ducrotte, P., Picard, C., Mouret, M., Mercier, C.H. and Matuchansky, C., 2007. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology and Therapeutics 26: 475-486.
'Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial ' () 26 Alimentary Pharmacology and Therapeutics : 475 -486.
-
Kajander, K., Myllyluoma, E., Rajilic-Stojanovic, M., Kyronpalo, S., Rasmussen, M., Jarvenpaa, S., Zoetendal, E.G., De Vos, W.M., Vapaatalo, H. and Korpela, R., 2008. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Alimentary Pharmacology and Therapeutics 27: 48-57.
'Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota ' () 27 Alimentary Pharmacology and Therapeutics : 48 -57.
-
Niedzielin, K., Kordecki, H. and Kosik, R., 1998. New possibility in the treatment of irritable bowel syndrome: probiotics as a modification of the microflora of the colon. Gastroenterology 114 Suppl. 1: A402.
-
Nobaek, S., Johansson, M.L., Molin, G., Ahrne, S. and Jeppsson, B. 2000., Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. American Journal of Gastroenterology 95: 1231-1238.
'Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome ' () 95 American Journal of Gastroenterology : 1231 -1238.
-
O'Sullivan, M.A. and O'Morain, C.A., 2000. Bacterial supplementation in the irritable bowel syndrome. A randomized double-blind placebo-controlled crossover study. Digestive Diseases and Sciences 32: 302-304.
'Bacterial supplementation in the irritable bowel syndrome ' () 32 A randomized double-blind placebo-controlled crossover study. Digestive Diseases and Sciences : 302 -304.
-
Ooi, L.G. and Liong, M.T., 2010. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. International Journal of Molecular Sciences 11: 2499-2522.
'Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings ' () 11 International Journal of Molecular Sciences : 2499 -2522.
-
Perdigon, G. and Alvarez, S., 1995. Probiotics and the immune state. In: Fuller, R. (ed.) Probiotics – the scientific basis. Chapman & Hall, London, UK, pp. 146-176.
-
Renner, H.W. and Munzner, R., 1991. The possible role of probiotics as dietary antimutagens. Mutation Research 262: 239-245.
'The possible role of probiotics as dietary antimutagens ' () 262 Mutation Research : 239 -245.
-
Rolfe, R.D., 2000. The role of probiotic cultures in the control of gastrointestinal health. Journal of Nutrition 130 Suppl. 2: 396S-402S.
-
Saavedra, J., 2000. Probiotics and infectious diarrhea. American Journal of Gastroenterology 95 Suppl.: S16-S18.
-
Saggioro, A., 2004. Probiotics in the treatment of irritable bowel syndrome. Journal of Clinical Gastroenterology 38 Suppl. 2: S104-S106.
-
Saito, Y.A., Locke, G.R., Weaver, A.L., Zinsmeister, A.R. and Talley, N.J., 2005. Diet and functional gastrointestinal disorders: a population-based case-control study. American Journal of Gastroenterology 100: 2743-2748.
'Diet and functional gastrointestinal disorders: a population-based case-control study ' () 100 American Journal of Gastroenterology : 2743 -2748.
-
Salminen, S., Wright, A.V., Morelli, L., Marteau, P., Brassart, D., De Vos, W.M., Fonden, R.F., Saxelin, M., Collins, K., Mogensen, G., Birkeland, S.E. and Mattila-Sandholm, T., 1998. Demonstration of safety of probiotics – a review. International Journal of Food Microbiology 44: 93-106.
'Demonstration of safety of probiotics – a review ' () 44 International Journal of Food Microbiology : 93 -106.
-
Vanderhoof, J.A. and Young, R.J., 1998. Use of probiotics in childhood gastrointestinal disorders. Journal of Pediatric Gastroenterology and Nutrition 27: 323-332.
'Use of probiotics in childhood gastrointestinal disorders ' () 27 Journal of Pediatric Gastroenterology and Nutrition : 323 -332.
-
Whorwell, P.J., Altringer, L., More, J., Bond, Y., Charbonneau, D., O'Mahony, L., Kiely, B., Shanahan, F. and Quigley, E.M., 2006. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. American Journal of Gastroenterology 101: 1581-1590.
'Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome ' () 101 American Journal of Gastroenterology : 1581 -1590.
-
Zani, J.L., Da Cruz, F.W., Dos Santos, A.F. and Turnes, C.G., 1998. Effect of probiotic CenBiot on the control of diarrhea and feed efficiency in pigs. Journal of Applied Microbiology 84: 68-71.
'Effect of probiotic CenBiot on the control of diarrhea and feed efficiency in pigs ' () 84 Journal of Applied Microbiology : 68 -71.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 321 | 118 | 19 |
| Gesamttextansichten | 8 | 0 | 0 |
| PDF-Downloads | 13 | 0 | 0 |
Effect of capsule 'UB03' containing potential probiotic strains for the treatment of patients with irritable bowel syndrome
in Beneficial Microbessudha.ratna@gmail.com
Search for other papers by M. Ratna Sudha in
Current site
Google Scholar
PubMed
Search for other papers by P. Sawant in
Current site
Google Scholar
PubMed
Abstract
The objective of this research was to study the efficacy and safety of capsule 'UB03' to treat patients with Irritable Bowel Syndrome (IBS). Thirty patients with Rome II IBS were assigned to receive capsule 'UB03' (10 billion lyophilised bacteria and yeast/capsule produced by Unique Biotech Limited, India) twice daily for 90 days. Assessment of IBS was carried out according with Rome II criteria and their severity for 90 days of treatment with an interval of 30 days. Complete haemogram, serum glutamic pyruvic transaminase, serum creatinine were performed as a part of safety evaluation at the time of inclusion and after 90 days of treatment. There was significant improvement in frequency of defecation (23%), consistency of stool, abdominal discomfort, bloating and flatulence. However, there was no significant change in abdominal pain and mucus in stool. This trial demonstrates that the consumption of capsule 'UB03' containing potential probiotic strains is found to be effective and safe for the treatment of patients with IBS.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 321 | 118 | 19 |
| Gesamttextansichten | 8 | 0 | 0 |
| PDF-Downloads | 13 | 0 | 0 |
